title: [Therapy of severe aplastic anemia (SAA) by bone marrow transplantation (BMT) or immunosuppression?].
authors.affiliation: Intensivblutbank des Allg. Krankenhauses, Wien, Osterreich.
authors.forename: P
authors.initials: P
authors.lastname: Höcker
authors.forename: W
authors.initials: W
authors.lastname: Hinterberger
authors.forename: H
authors.initials: H
authors.lastname: Gadner
authors.forename: A
authors.initials: A
authors.lastname: Hajek-Rosenmayr
authors.forename: M
authors.initials: M
authors.lastname: Fischer-Hinterberger
authors.forename: M
authors.initials: M
authors.lastname: Kos
authors.forename: W
authors.initials: W
authors.lastname: Emminger
authors.forename: S
authors.initials: S
authors.lastname: Panzer
authors.forename: K
authors.initials: K
authors.lastname: Lechner
mesh_terms: D000208:Acute Disease; D000741:Anemia, Aplastic / Q000401:mortality / Q000628:therapy*; D000961:Antilymphocyte Serum / Q000008:administration & dosage / Q000009:adverse effects; D016026:Bone Marrow Transplantation; D006801:Humans; D007165:Immunosuppression Therapy; D008775:Methylprednisolone / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D000961:Antilymphocyte Serum; D008775:Methylprednisolone
vernacular_title: Therapie der schweren aplastischen Anämie (SSA) durch Knochenmarktransplantation (KMT) oder Immunsuppression?